Physician profile
Dee Wu
NPI 1871640334
$2,810.03
in general payments reported to CMS, 2019-2025
11 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,429 · 2020: $71.09 · 2021: $116 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $2,056.42 | 2019 | |
| Amgen INC. | $291.89 | 2019-2025 | Evenity |
| Pfizer INC. | $136.78 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $77.35 | 2019 | |
| Abbvie INC. | $68.26 | 2019-2021 | |
| Ucb, INC. | $57.75 | 2019 | |
| Radius Health, INC. | $56.56 | 2020 | |
| Genzyme Corporation | $27.50 | 2019 | |
| Glaxosmithkline, LLC. | $13.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.79 | 2019 | |
| Depuy Synthes Sales INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dee Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.